title: Comparison of erbium:YAG and carbon dioxide lasers in resurfacing of facial rhytides.
abstract: OBJECTIVE
  To compare the efficacy, adverse effects, and histological findings of erbium:YAG (Er:YAG) and carbon dioxide (CO2) laser treatment in removing facial rhytides.
  
  
  METHODS
  An intervention study of 21 subjects with facial rhytides. All participants were followed up for 6 months. The end points of the study were wrinkle improvement and duration of adverse effects.
  
  
  METHODS
  Academic referral center.
  
  
  METHODS
  Nineteen female and 2 male volunteers with skin type I to III and wrinkle class I to III participated in the study.
  
  
  METHODS
  In all subjects, 1 side of the face was treated with a CO2 laser and other side with an Er:YAG laser. Skin biopsies were performed in 6 subjects before treatment and immediately, 1 day, 2 days, and 6 months after treatment. Observations were recorded by subjects, investigators, and a blinded panel of experts.
  
  
  METHODS
  Improvement in wrinkles and severity and duration of adverse effects.
  
  
  RESULTS
  The CO2 laser-treated side had relatively better wrinkle improvement when evaluating all subjects (P<.03). However, in subjects receiving more than 5 passes of Er:YAG laser, improvement scores were not significantly different from those for 2 to 3 passes of CO2 laser treatment. Posttreatment erythema was noted at 2 weeks in 14 subjects (67%) on the Er:YAG laser-treated side and 20 subjects (95%) on the CO2 laser-treated side. The frequency of erythema was significantly less after Er:YAG laser treatment at 2 (P=.001) and 8 (P=.03) weeks. Hypopigmentation was seen in 1 Er:YAG-treated (5%) and 9 CO2-treated (43%) sides (chi2, P<.05). Histological evaluation showed residual thermal damage of up to 50 microm on the Er:YAG-treated side and up to 200 microm on the CO2-treated side.
  
  
  CONCLUSIONS
  Erbium:YAG laser is safe and effective in removing facial rhytides. Subjects treated with Er:YAG laser recover more quickly from the procedure than those receiving CO2 laser treatment.
authors: Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
authors: K A
authors: KA
authors: Khatri
authors: V
authors: V
authors: Ross
authors: J M
authors: JM
authors: Grevelink
authors: C M
authors: CM
authors: Magro
authors: R R
authors: RR
authors: Anderson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002245:Carbon Dioxide; D004871:Erbium; D005260:Female; D006801:Humans; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D015361:Rhytidoplasty / Q000379:methods*; D015595:Skin Aging / Q000473:pathology
chemical_list: D002245:Carbon Dioxide; D004871:Erbium